Skip to main content

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

At the Diabetes UK Conference which was held last week in Manchester Professor Anna Gloyn took part in a special session celebrating Diabetes UK funded fellows past and present.

At the Diabetes UK Conference which was held last week in Manchester Professor Anna Gloyn took part in a special session celebrating Diabetes UK funded fellows past and present.  For more information see” Handing over the baton in diabetes research, by Kotryna Temcinaite – Diabetes UK Blogs”

Similar stories

New research will map the impact of sleep and circadian rhythm disruption on cardiometabolic disease

In the UK more than 4.3 million people live with Type-2 Diabetes, and 2.4 million more are at increased risk of developing the disease. Type-2 Diabetes, obesity, hypertension, and fatty liver disease frequently cluster together in the same individuals. It is becoming clear that sleep and body clock problems have a role to play in this ‘cardiometabolic multimorbidity’, but its exact nature is under-researched.